Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer

Bibliographic Details
Main Authors: Mengjun Zhang, Yunduo Liu, Yuan Liu, Siyu Hou, Hao Li, Ying Ma, Can Wang, Xiuwei Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.978493/full
_version_ 1817998370855190528
author Mengjun Zhang
Yunduo Liu
Yuan Liu
Siyu Hou
Hao Li
Ying Ma
Can Wang
Xiuwei Chen
author_facet Mengjun Zhang
Yunduo Liu
Yuan Liu
Siyu Hou
Hao Li
Ying Ma
Can Wang
Xiuwei Chen
author_sort Mengjun Zhang
collection DOAJ
first_indexed 2024-04-14T02:52:15Z
format Article
id doaj.art-449c844b60eb481b911f9621b506a2be
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-14T02:52:15Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-449c844b60eb481b911f9621b506a2be2022-12-22T02:16:14ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-08-011310.3389/fgene.2022.978493978493Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancerMengjun Zhang0Yunduo Liu1Yuan Liu2Siyu Hou3Hao Li4Ying Ma5Can Wang6Xiuwei Chen7Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gynecology, Beijing Shijitan Hospital, Capital Medical University, Beijing, ChinaDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, ChinaDepartment of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Chinahttps://www.frontiersin.org/articles/10.3389/fgene.2022.978493/fullarrestin domain containing 2biomarkerimmunityprognosisovarian cancer
spellingShingle Mengjun Zhang
Yunduo Liu
Yuan Liu
Siyu Hou
Hao Li
Ying Ma
Can Wang
Xiuwei Chen
Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
Frontiers in Genetics
arrestin domain containing 2
biomarker
immunity
prognosis
ovarian cancer
title Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_full Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_fullStr Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_full_unstemmed Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_short Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
title_sort corrigendum a potential indicator arrdc2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
topic arrestin domain containing 2
biomarker
immunity
prognosis
ovarian cancer
url https://www.frontiersin.org/articles/10.3389/fgene.2022.978493/full
work_keys_str_mv AT mengjunzhang corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT yunduoliu corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT yuanliu corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT siyuhou corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT haoli corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT yingma corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT canwang corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer
AT xiuweichen corrigendumapotentialindicatorarrdc2hasfeasibilitytoevaluateprognosisandimmunemicroenvironmentinovariancancer